Trials / Completed
CompletedNCT04602871
Early Detection of COVID-19 Using Breath Analysis - Feasibility Study
Early Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Scentech Medical Technologies Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Early Detection of COVID-19 Using Breath Analysis -Feasibility Study.
Detailed description
An interventional diagnostic prospective study study with risks and minimal constraints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Breath Biopsy | Breath Biopsy sampling using the ReCIVA® Breath Sampler |
Timeline
- Start date
- 2020-07-03
- Primary completion
- 2021-01-30
- Completion
- 2021-01-30
- First posted
- 2020-10-26
- Last updated
- 2022-05-10
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT04602871. Inclusion in this directory is not an endorsement.